CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
About this item
Full title
Author / Creator
Hirata, K , Suzuki, H , Imaeda, H , Matsuzaki, J , Tsugawa, H , Nagano, O , Asakura, K , Saya, H and Hibi, T
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background:
Multiple early gastric cancers (EGCs) may develop in 6–14% of patients even after achieving curative endoscopic submucosal dissection (ESD); however, a useful biomarker for predicting recurrence is not available. The present study investigated whether the expression of CD44 variant 9 (CD44v9), a functional cancer stem cell marker, in...
Alternative Titles
Full title
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3721391
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3721391
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/bjc.2013.314
